Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
Roche's oral SERD notches second pivotal breast cancer win FirstWord Pharma
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial Fierce Biotech
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
Roche oral drug shown to keep breast cancer at bay, boosting shares Reuters